AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2016

Jun 16, 2016

32566_dirs_2016-06-16_abeab314-d7ae-467d-b651-4101f6bdb38c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2016-06-16

Reporting Person: MARSH RICHARD M (E.V.P., General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-16	Common Stock	M	4170.0	$23.98	Acquired	73309	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-16	Incentive Stock Option (right to buy)	$23.98	M	4170.0	Disposed	2022-03-07	Common Stock (4170)	Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.